Extracellular adenosine 5′-triphosphate modulates interleukin-6 production by human thyrocytes through functional purinergic P2 receptors

被引:17
作者
Caraccio, N
Monzani, F
Santini, E
Cuccato, S
Ferrari, D
Callegari, MG
Gulinelli, S
Pizzirani, C
Di Virgilio, F
Ferrannini, E
Solini, A
机构
[1] Univ Pisa, Dept Internal Med, Sect Internal Med 3, I-56100 Pisa, Italy
[2] Univ Ferrara, Sect Gen Pathol, Interdisciplinary Ctr Study Inflammat, Dept Expt & Diagnost Med, I-44100 Ferrara, Italy
关键词
D O I
10.1210/en.2004-1527
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated the presence of P2 receptors (P2Rs) in human thyrocytes and their possible involvement in the modulation of cytokine release. P2Rs expression was assessed by RT-PCR and, when possible, by immunoblotting. Human primary thyrocytes express the mRNA for the following P2X and P2Y subtypes: P2X(3), P2X(5), P2X(6), P2X(7), and P2Y(1), P2Y(2), P2Y(4), and P2Y(11). Stimulation with extracellular nucleotides of fura-2-loaded thyrocytes triggered an intracellular Ca2+ signal, suggesting expression of functional receptors. Thyrocytes spontaneously released the proinflammatory cytokine IL-6. The ATP-hydrolyzing enzyme apyrase reduced basal IL-6 release, whereas extracellular ATP dose-dependently increased IL-6 secretion. Uridine 5'-triphosphate was also an effective stimulus, whereas benzoyl-ATP was ineffective, suggesting a P2Y- rather than P2X-modulated response. Finally, TSH reduced both the intracellular Ca2+ ([Ca2+](i)) rise and IL-6 release triggered by P2Rs stimulation. In conclusion, we provide functional, pharmacological, and biochemical evidence that human primary thyrocytes express P2YR and P2XR subtypes, coupled to increases in ([Ca2+](i)) and secretion of IL-6. P2R-dependent modulation of IL-6 release from human thyrocytes suggests a novel mechanism whereby an inflammatory and/or immune-mediated damage can be initiated and amplified in the thyroid.
引用
收藏
页码:3172 / 3178
页数:7
相关论文
共 37 条
[1]   Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family [J].
Abbracchio, MP ;
Boeynaems, JM ;
Barnard, EA ;
Boyer, JL ;
Kennedy, C ;
Miras-Portugal, MT ;
King, BF ;
Gachet, C ;
Jacobson, KA ;
Weisman, GA ;
Burnstock, G .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (02) :52-55
[2]   Cytokines in thyroid autoimmunity [J].
Ajjan, RA ;
Weetman, AP .
AUTOIMMUNITY, 2003, 36 (6-7) :351-359
[3]   INTERLEUKIN-6 AND THE THYROID [J].
BARTALENA, L ;
BROGIONI, S ;
GRASSO, L ;
MARTINO, E .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1995, 132 (04) :386-393
[4]   Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase [J].
Beigi, R ;
Kobatake, E ;
Aizawa, M ;
Dubyak, GR .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1999, 276 (01) :C267-C278
[5]   Induced illness in interleukin-6 (IL-6) knock-out mice: A causal role of IL-6 in the development of the low 3,5,3'-triiodothyronine syndrome [J].
Boelen, A ;
Maas, MAW ;
Lowik, CWGM ;
Platvoet, MC ;
Wiersinga, WM .
ENDOCRINOLOGY, 1996, 137 (12) :5250-5254
[6]   Relation between serum interleukin-6 and thyroid hormone concentrations in 270 hospital in-patients with non-thyroidal illness [J].
Davies, PH ;
Black, EG ;
Sheppard, MC ;
Franklyn, JA .
CLINICAL ENDOCRINOLOGY, 1996, 44 (02) :199-205
[7]  
Di Virgilio Francesco, 2001, Trends in Pharmacological Sciences, V22, P5
[8]   Mechanisms of P2 receptor-evoked DNA synthesis in thyroid FRTL-5 cells [J].
Ekokoski, E ;
Webb, TE ;
Simon, J ;
Törnquist, K .
JOURNAL OF CELLULAR PHYSIOLOGY, 2001, 187 (02) :166-175
[9]   Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin [J].
Ferrari, D ;
Chiozzi, P ;
Falzoni, S ;
Hanau, S ;
DiVirgilio, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (03) :579-582
[10]  
Ferrari D, 1997, J IMMUNOL, V159, P1451